Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 5:51 AM ET


Company Overview of Allergan, Inc.

Executive Profile

David E. I. Pyott

Chairman and Chief Executive Officer, Allergan, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. David E. I. Pyott serves as the President of the Pan-American Ophthalmological Foundation. Mr. Pyott serves as Vice Chairman of the Chief Executive Roundtable for UCI. Mr. Pyott is a leader in specialty pharmaceutical markets and a medical aesthetics pioneer and has more than thirty years of international business experience in the pharmaceutical industry. He served as the Chairman and Chief Executive Officer of Allergan Inc. since April 2001 and since January 1998 ...

Corporate Headquarters

400 Interpace Parkway
Parsippany, New Jersey 07054

United States

Phone: 862-261-7000
Fax: --

Board Members Memberships

Director and Member of Investment & Finance Committee
Director At Large
Chairman and Chief Executive Officer
Lead Independent Director, Chairman of Compensation & Executive Personnel Committee and Member of Governance & Social Responsibility Committee


London Business School
University of Edinburgh in Scotland

Other Affiliations

Annual Compensation

Total Annual Compensation$1,401,269

Stocks Options

All Other Compensation$52,136
Exercised Options$252,000
Exercised Options Value$21,915,760
Exercisable Options$2,265,200
Exercisable Options Value$343,106,749
Unexercisable Options$734,756
Unexercisable Options Value$79,105,693
Total Value of Options$444,128,201
Total Number of Options$3,251,956

Total Compensation

Total Annual Cash Compensation$3,674,205
Total Short Term Compensation$1,401,269
Other Long Term Compensation$52,136
Total Calculated Compensation$17,785,957

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Allergan, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at